Volume : 11, Issue : 01, January – 2024

Title:

PROBIOTICS – ARTICLE REVIEW

Authors :

PT. Nagaraju*, B. V Ramana*, S. Abhinaya

Abstract :

Probiotics are used in a large variety of fields relevant to human and animal health. For some decades now, bacteria known as probiotics have been added to various foods because of their beneficial effects for human health. The number of products containing probiotics, viable bacteria with proven health benefits, entering the market is increasing. Traditionally, probiotics have been associated with gut health, and the oral consumption of probiotic microorganisms produces a protective effect on the gut flora. Lots of studies suggest that probiotics have beneficial effects on microbial disorders of the gut. They are known to have a positive therapeutic effect against traveller’s diarrhoea, antibiotic associated diarrhoea and acute diarrhoea. Use of probiotics helps to protect the host from various intestinal disorders by increasing the number of beneficial bacteria. The most commonly used microorganisms in probiotic products are the lactic acid bacteria (LAB) and it is important to know how these LAB affect the immune status of the consumer. The discovery that probiotics can stimulate an immune response provides a scientific basis for some of the observed probiotic effects.
KEYWORDS: Probiotics, lactic acid bacteria, gut flora, Classification and identification, MOA, Benefits.

Cite This Article:

Please cite this article in press Puduru Thogata Nagaraju et al., Probiotics – Article Review, Indo Am. J. P. Sci, 2024; 11 (01).

Number of Downloads : 10

References:

1. Aiba Y, Suzuki N, Kabir AMA, Takagi A, Koga Y (1998): Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol, 93:2097-2101
2. Aguirre M, Collins, MD (1993): Lactic acid bacteria and human clinical infection. J
Appl Bacterial, 75: 95-107
3. Andersson H, Asp N-G, Bruce A, Roo’s S, Wadstrom T, World AE (2001): Health effects of probiotics and prebiotics: A literature review on human studies. Scand J Nutr, 45: 58-75
4. Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A (2001): The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther, 15(2): 163-169
5. Arunachalam K, Gill HS, Chandra RK (2000): Enhancement of natural immunity function by dietary consumption of Bifidobacterium lactis HN019. European J Clin Nutr 54: 1-4.
6. Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, Isolauri E (1999): Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics, 104(5): 1-4.
7. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S (1995): Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group Eur Urol, 27: 104-9.
8. Bennet R, Eriksson M, Nord CE, Zetterstrom R (1986): Fecal bacterial microflora of new-born infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis, 5: 533-9.
9. Bernet-Camarad MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S (1997): The human Lactobacillus acidophilus strain La-1 secrets a non-bacteriocin antibacterial substances active in vivo and in vitro. Appl Environ Microbial, 63: 2747-2753.
10. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL (1995): Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr, 21: 224-6.
11. CAC (1997): General Requirements (Food Hygiene). Supplement to Vol. 1. B. Joint FAO/WHO Food Standards Programme, FAO, Rome.
12. Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A, (2000): A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther, 14: 1625-9.
13. Coconnier MH, Bernet MF, Kerneis S, Chauviere G, Fourniat J, Servin AL (1993): Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett, 110: 299-306.